Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

9/21/2026
Impact: 75
Healthcare

Truist Securities analyst David Macdonald has maintained a 'Buy' rating on Labcorp Holdings (NYSE: LH) and increased the price target from $350 to $365. This adjustment reflects a positive outlook for the company's performance in the market.

AI summary, not financial advice

Share: